摘要:
The design and synthesis of a novel class of human bradykinin B, antagonists featuring difluoroethyl ether and isoxazole carboxamide moieties are disclosed. Compound 7g displayed excellent pharmacokinetic properties, efficient ex vivo receptor occupancy, and low potential for P450 induction via PXR activation. (c) 2008 Published by Elsevier Ltd.